[go: up one dir, main page]

FI20011542A7 - Uroginaasigeenin monistuman käyttö - Google Patents

Uroginaasigeenin monistuman käyttö Download PDF

Info

Publication number
FI20011542A7
FI20011542A7 FI20011542A FI20011542A FI20011542A7 FI 20011542 A7 FI20011542 A7 FI 20011542A7 FI 20011542 A FI20011542 A FI 20011542A FI 20011542 A FI20011542 A FI 20011542A FI 20011542 A7 FI20011542 A7 FI 20011542A7
Authority
FI
Finland
Prior art keywords
gene amplification
carcinomas
uroginase
relates
present
Prior art date
Application number
FI20011542A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI20011542A0 (fi
FI20011542L (fi
Inventor
Merja Helenius
Merja Saramäki
Marika Linja
Teuvo Tammela
Tapio Visakorpi
Original Assignee
Fit Biotech Oyj Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fit Biotech Oyj Plc filed Critical Fit Biotech Oyj Plc
Priority to FI20011542A priority Critical patent/FI20011542L/fi
Publication of FI20011542A0 publication Critical patent/FI20011542A0/fi
Priority to PCT/FI2002/000636 priority patent/WO2003006690A1/fr
Publication of FI20011542A7 publication Critical patent/FI20011542A7/fi
Publication of FI20011542L publication Critical patent/FI20011542L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI20011542A 2001-07-13 2001-07-13 Urosognaasigeenin monistuman käyttö FI20011542L (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20011542A FI20011542L (fi) 2001-07-13 2001-07-13 Urosognaasigeenin monistuman käyttö
PCT/FI2002/000636 WO2003006690A1 (fr) 2001-07-13 2002-07-15 Utilisation de l'amplification genetique d'urokinase comme marqueur

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20011542A FI20011542L (fi) 2001-07-13 2001-07-13 Urosognaasigeenin monistuman käyttö

Publications (3)

Publication Number Publication Date
FI20011542A0 FI20011542A0 (fi) 2001-07-13
FI20011542A7 true FI20011542A7 (fi) 2003-01-14
FI20011542L FI20011542L (fi) 2003-01-14

Family

ID=8561659

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20011542A FI20011542L (fi) 2001-07-13 2001-07-13 Urosognaasigeenin monistuman käyttö

Country Status (2)

Country Link
FI (1) FI20011542L (fr)
WO (1) WO2003006690A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2886946B1 (fr) * 2005-06-09 2007-08-10 Biomerieux Sa Procede pour le diagnoctic/pronostic du cancer du sein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422090A (en) * 1984-08-13 1995-06-06 Biotechnology Australia, Pty., Ltd. Human PAI-2
AU733222B2 (en) * 1997-11-25 2001-05-10 Genentech Inc. Fibroblast growth factor-19

Also Published As

Publication number Publication date
WO2003006690A1 (fr) 2003-01-23
FI20011542A0 (fi) 2001-07-13
FI20011542L (fi) 2003-01-14

Similar Documents

Publication Publication Date Title
DK3059322T3 (da) Genekspressionsmarkører for brystcancerprognose
ATE393240T1 (de) Verfahren zum nachweis von prostatakrebs
DE69942827D1 (de) Verwendung der epothilons zur behandlung der krebs
ATE538215T1 (de) Expressionsprofil von prostatakarzinom
WO2006012646A3 (fr) Marqueurs de cancers amacr
WO2003089904A3 (fr) Aib1 utilise en tant que marqueur pronostique et predicteur de la resistance a l'endocrinotherapie
DE69940436D1 (de) Prostata stammzellantigen (psca) und dessen verwendungen
AU2003253986A8 (en) Gene expression profiling in biopsied tumor tissues
EA200801037A1 (ru) Ингибиторы фосфатидилинозит-3-киназы и способы их применения
WO2001070979A3 (fr) Nouveaux genes, compositions, trousses et methodes d'identification, de verification, de prevention et de traitement du cancer des ovaires
TW200628469A (en) Disubstituted pyrazolobenzodiazepines
WO2008031839A3 (fr) Signature d'expression génique destinée à améliorer le pronostic, le diagnostic et le traitement du cancer de la prostate, et utilisations associées
WO2007056049A3 (fr) Profilage moleculaire de cancer
HUP0303649A2 (hu) Mátrix-metalloproteináz-inhibitorok liposzómás célzása
FI20002127A0 (fi) Uusi vasta-aine, immunomääritys ja menetelmä eturauhassyövän havaitsemiseksi
FR2875601B1 (fr) Vimentine phosphorylee comme marqueur de l'agressivite et/ou l'invasivite des tumeurs
FI20011542A7 (fi) Uroginaasigeenin monistuman käyttö
EP1451552A4 (fr) Reactifs et methodes utiles dans la detection de maladies du sein
TW200517122A (en) Antibodies specific for cancer associated antigen SM5-1 and uses thereof
EP1285970A3 (fr) Procédé d'identification de gènes associés à des métastases de tumeur
WO2009013075A3 (fr) Marqueurs de l'invasion dans un carcinome du sein et du poumon
CY1111289T1 (el) Συνθεσεις αναστολεων ογκου που περιεχουν νιτροακριδινη
ATE409226T1 (de) Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)
MX2007005501A (es) Asociacion tumoral de mieloide de lectina-1 asociada a dap12 y metodos.
DE60226956D1 (de) Verstärktes krebs-gen wip1